Amarin Corp Plc (AMRN)

[hamkypamky]

I mean I am not saying a BO for $75 cannot happen in the near future, I am just saying it's unlikely that's all.

There are some seriously desperate BPs out there. Novartis and their CRL for canakinumab after the failure of most of it's cardio efforts certainly makes it more likely to fall into that "desperation" category.

But NVS is still a big name, with a large pipeline, unlike the AbbVie / PCYC situation, so it could stay on the sidelines for a while yet.